Simultaneous Determination for Lansoprazole and Simvastatin drugs via Ultraviolet Spectrophotometry

Main Article Content

Imad T. Hanoon

Abstract

A semi-novel, accurate, sensitive, simple, requiring no prior separation and economical procedures have been developed for the simultaneous analysis of binary mixture of Lansoprazole (Lanso) and Simvastatin (Semva). The first method is the Derivative of ratio spectra, in which the absorption spectrum of one drug as interfering drug were subtracted from the absorption spectrum of the mixture and then the net spectrum derivative, the first derivative (for Lanso) and second derivative (for Semva). Beer’s law was obeyed in the concentration ranges of (1-90) and (4-70) μg.ml-1 and the results showed that the method was precise and accurate with RSD% of (0.0161-0.0235), (0.0360-0.0525) and R.E% (0.3125-0.4545), (-0.0909-0.0312) for Lanso and Semva respectively. The second method based on ratio difference, where the absorption spectrum of mixtures the drugs was divided by the on the absorption spectrum of a suitable the interfering drug. The difference in peak amplitudes between the two selected wavelengths in the ratio spectra were recorded for each drug. Beer’s law was obeyed in the concentration ranges of (0.1-30) and (1-40) μg.ml-1 and the results of the method were precise and accurate with RSD% of (0.2880-0.4580), (0.1294-0.9880) and R.E% of (-0.0090-0.0909), (-0.0651-0.0710) for Lanso and Semva respectively of this method.


The proposed methods were successfully applied for the determination of the two compounds. 

Article Details

How to Cite
Imad T. Hanoon. (2023). Simultaneous Determination for Lansoprazole and Simvastatin drugs via Ultraviolet Spectrophotometry. Tikrit Journal of Pure Science, 22(8), 103–111. https://doi.org/10.25130/tjps.v22i8.858
Section
Articles

References

1- Current Index of Medical Specialities (CIMS),

CMP Medica India Pvt Ltd, Bangalore, India, 2005,

72.

2- K. Basavaiah, V. Ramakrishna, U.R. Anil kumar1

and B.C. Somashekar, Ecl. Quím, São Paulo, 32(1):

2007, 57-64.

3- E. Leitersdorf, Int. J. Clin Pract. 56 Suppl 2:

2002, 116-9.

4- M. Heek, C. Farley and D. Compton, J.

Pharmacol, 134: 2001, 409-17.

5- C. Bala Sekharan1, M. Prasada Rao, Sk.

Naseema, G. Suresh Kumar and B. Alekhya, App.

Sci. Report, 10(2): 2015, 105-11.

6- I, Rizwana1, K. Prakash and G. Mohan, Chem Sci

Trans, 3(4), 2014, 1390-95.

7- O. Devi, K. Basavaiah, K. Vinay, Journal of Saudi

Chemical Society,17: 2013, 387–96.

8- R. Kachave, M. Kale and R. Wagh,, The Open

Analytical Chemistry Journal, 8: 2015, 7-11.

9- N. Choudhary, I. Siddiqui, J. Rai, S. Singh, S.

Surabhi and H. Gautam, Der Pharma Chemica, 5(2):

2013, 67-74.

10- H. Lotfy, Int J Pharm Pharm Sci, Vol 4 Suppl 4:

2012, 673-79.

11- H. Lotfy, Int J Pharm Pharm Sci, 6(1): 2014, 735-

41.

12- S. Abdel-Naby and Z. Abdelaziz, European

Journal of Chemistry, 3(4): 2012.

13- H. Lotfy and M, Hegazy, Spectrochimica Acta

Part A: Molecular and Biomolecular Spectroscopy,

113: 2013, 107–114.

14- H. Lotfy, M. Hegazy and A. Abdel-Gawad,

European Journal of Chemistry, 4(4): 2013.

15- N. Magdy and M. Ayad, Spectrochimica Acta

Part A: Molecular and Biomolecular Spectra, 137:

2015, 685–91.

16- A. Sayed and M. Khalil, Talanta, 43(4): 1996,

583.

17- D. Dogrukol - Ak, M. Tuncel, H. Aboul - Enein,

Short Communication Column Liquid

Chromatography Chromatographia, 54(7): 2001, 527-

30.

18- A. Munir, M. Ahmad, M. Zubair and M. Minhas,

rop J Pharm Res, 13(1): 2014, 135-39.

19- S. Silva, G. Rezende and V. Borall, Braz. J.

Pharm. Scim, 50(3): 2014.